Importance of HCV genotype 1 subtypes for drug resistance and response to therapy.
about
Profile of paritaprevir/ritonavir/ombitasvir plus dasabuvir in the treatment of chronic hepatitis C virus genotype 1 infectionAge and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central ChinaIn-depth phylogenetic analysis of hepatitis C virus subtype 1a and occurrence of 80K and associated polymorphisms in the NS3 proteaseHigh-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methodsManagement of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant.Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.Predictive factors associated with hepatitis C antiviral therapy response.Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors.Comprehensive Screening for Naturally Occurring Hepatitis C Virus Resistance to Direct-Acting Antivirals in the NS3, NS5A, and NS5B Genes in Worldwide Isolates of Viral Genotypes 1 to 6Secondary Structural Elements of the HCV X-region Involved in Viral ReplicationPhylogenetic analysis of HCV subgenotypes in patients from Sichuan province in China based on the NS5B region.Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort.Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus.Biomedical Mutation Analysis (BMA): A software tool for analyzing mutations associated with antiviral resistanceOmbitasvir/paritaprevir/ritonavir and dasabuvir tablets for hepatitis C virus genotype 1 infection.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens.Consolidation of molecular testing in clinical virology.HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.Resistance to DAAs: When to Look and When It Matters.The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort.Hepatitis C virus: Morphogenesis, infection and therapy.
P2860
Q26775825-E2437600-6F5B-42C7-B5CD-211C7C9ECE91Q27468718-EDC23856-402A-4719-B573-CCDC4159F15DQ27468875-FDE9E016-5662-40C3-9951-2D46E660DA6EQ28652352-243D5762-A079-4EB3-B6E6-45427944BC41Q35626794-9C10B98B-8640-4254-BC31-46AD363F5175Q35757761-A8985622-5B66-46DF-9602-7A074B0BF77DQ35790397-4B9A0798-3EBB-4262-9CD9-0681FBFE77F7Q35880497-DC2CB57F-B107-4E10-A05C-D46AAF385B1EQ35917596-5B8723E2-F557-40D3-8DF8-78F8CBA8D9CEQ35972684-8CA66F2A-3329-4B54-9E65-2AE2F019B84AQ36041672-5B23CE5E-F0BE-4426-8AE2-BFD53D22A365Q36166222-EB2D4447-7524-46C0-8B4C-6328230F0A72Q36506480-C5885C2F-C7C3-4E3A-ADCA-C78555261E50Q36531731-6E48FAE7-6A0A-41B2-8F89-076B97B12490Q37174078-07CB8C73-AB9D-45FB-9173-E10E53288F49Q38355057-7953D171-8406-416E-AE83-C5102FEF65DBQ38515906-B951F134-DFBD-427E-9E48-2FD796D26452Q38618427-DBCF95A2-E2EF-4D37-BCF0-52D02F4D32F8Q38779627-C0DFCE2A-8280-4C4C-A9A0-0D50F093B81CQ39018557-259B6093-D075-4C86-9D68-3E202F3B9B39Q40867184-8D5C38C9-5CF7-45CB-B0A0-E08BA255F30EQ50108357-43612F03-7C36-47C1-B99D-AAE3926F7A70Q52656603-5A8C146B-9331-4106-9B2B-9621E33AB6C3Q52661702-43133098-ADC6-4F6B-B864-03DEBA034E45
P2860
Importance of HCV genotype 1 subtypes for drug resistance and response to therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Importance of HCV genotype 1 subtypes for drug resistance and response to therapy.
@en
type
label
Importance of HCV genotype 1 subtypes for drug resistance and response to therapy.
@en
prefLabel
Importance of HCV genotype 1 subtypes for drug resistance and response to therapy.
@en
P2860
P356
P1476
Importance of HCV genotype 1 subtypes for drug resistance and response to therapy.
@en
P2093
J A Gutierrez
P2860
P304
P356
10.1111/JVH.12230
P577
2014-04-01T00:00:00Z